LRRK2 and Parkinson disease: Similarly, impairments in Rab8a or Rab10 function result in endolysosomal trafficking deficits that mirror those observed with the pathogenic G2019S mutation in LRRK2, a mutation linked to Parkinson’s disease, and are accompanied by a diminished Rab7 activity83.